Drug Target Review – Issue 2 2019

Posted: 5 June 2019 | | No comments yet

In this issue: novel approaches to produce radiolabelled antibodies, the use of CRISPR/Cas9 to accelerate the development of targeted therapies and utilisation of stem cells to study the effects of cannabis on neuronal development.

Included in this issue:

    Radiochemistry and drug synthesis ‘in a flash’
    Professor Dr Jason P. Holland, University of Zurich, Switzerland
    Bringing native analysis into the fast-moving world of biologics
    Christopher Nortcliffe, Applications Specialist, LC/MS Biologics and Biopharma, SCIEX
    Phenotypic profiling in drug discovery
    Sean Lin, Ina Rothenaigner, Kamyar Hadian
    High-content imaging: challenges of the 3D world
    Margaritha M. Mysior and Jeremy C. Simpson, UCD Cell Screening Laboratory, School of Biology & Environmental Science, University College Dublin, Ireland    
    Stem-cell technologies in immunotherapy 
    Aparajita DubeyAssociate Scientific Manager, Biocon Biologics Limited, Bangalore, India

The rest of this content is restricted - login or subscribe free to access

Screening the future innovations in drug discoveryThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here


Leave a Reply

Your email address will not be published. Required fields are marked *